Skip to main content
SpringerLink
Log in

Pathogenesis by Aerosol

  • Chapter
Biological Weapons Defense

Part of the book series: Infectious Disease ((ID))

Abstract

Aerosols are the most likely and effective mode of dissemination of a bioterrorist agent whether it is a toxin or a bacterial or viral agent. The ideal biological threat agent would be delivered in a particle size that would allow it to persist suspended in the air for long periods of time and be inhaled deeply into the lungs of unsuspecting victims. The size range of particles that meet both of these criteria is 1–5 µm in diameter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Schlesinger, R. B. (1985) Comparative deposition of inhaled aerosols in experimental animals and humans: a review. J. Toxicol. Environ. Health 15, 197–214.

    Article  PubMed  CAS  Google Scholar 

  2. Asgharian, B., Wood, R., and Schlesinger, R. B. (1995) Empirical modeling of particle deposition in the alveolar region of the lungs: a basis for interspecies extrapolation. Fundam. Appl. Toxicol. 27, 232–238.

    Article  PubMed  CAS  Google Scholar 

  3. Lippmann, M. and Schlesinger, R. B. (1984) Interspecies comparisons of particle deposition and mucociliary clearance in tracheobronchial airways. J. Toxicol. Environ. Health 13, 441–469.

    PubMed  CAS  Google Scholar 

  4. Schlesinger, R. B., Gurman, J. L., and Lippmann, M. (1982) Particle deposition within bronchial airways: comparisons using constant and cyclic inspiratory flows. Ann. Occup. Hyg. 26, 47–64.

    Article  PubMed  CAS  Google Scholar 

  5. Yeates, D. B., Gerrity, T. R., and Garrard, C. S. (1981) Particle deposition and clearance in the bronchial tree. Ann. Biomed. Eng. 9, 577–592.

    Article  PubMed  CAS  Google Scholar 

  6. Lippmann, M., Yeates, D. B., and Albert, R. E. (1980) Deposition, retention, and clearance of inhaled particles. Br. J. Ind. Med. 37, 337–362.

    PubMed  CAS  Google Scholar 

  7. Oberdorster, G., Ferin, J., and Lehnert, B. E. (1994) Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 102(Suppl 5), 173–179.

    Article  PubMed  Google Scholar 

  8. Schlesinger, R. B. (1985) Clearance from the respiratory tract. Fundam. Appl. Toxicol. 5, 435–450.

    Article  PubMed  CAS  Google Scholar 

  9. Stuart, B. O. (1976) Deposition and clearance of inhaled particles. Environ. Health Perspect. 16, 41–53.

    Article  PubMed  CAS  Google Scholar 

  10. Stuart, B. O. (1984) Deposition and clearance of inhaled particles. Environ. Health Perspect. 55, 369–390.

    Article  PubMed  CAS  Google Scholar 

  11. Swift, D. L. (1981) Aerosol deposition and clearance in the human upper airways. Ann. Biomed. Eng. 9, 593–604.

    Article  PubMed  CAS  Google Scholar 

  12. Wilkey, D. D., Lee, P. S., Hass, F. J., et al. (1980) Mucociliary clearance of deposited particles from the human lung: intra-and inter-subject reproductivity, total and regional lung clearance, and model comparisons. Arch. Environ. Health 35, 294–303.

    PubMed  CAS  Google Scholar 

  13. (1966) Task Group on Lung Dynamics for Committee II of the International Commision on Radiological Protection, Deposition and Retention Models. Health Physics 12, 173–208.

    Google Scholar 

  14. Hounam, R. F. and Morgan, A. (1977) Particle deposition, in: Lung Biology in Health and Disease. Vol. 5 Respiratory Defense Mechanisms, Part I. (Lenfant, C., ed.), Marcal Dekker, Bethesda, Maryland, pp. 125–156.

    Google Scholar 

  15. Proctor, D. F. (1977) The upper airways. I. Nasal physiology and defense of the lungs. Am. Rev. Respir. Dis. 115, 97–129.

    PubMed  CAS  Google Scholar 

  16. Proctor, D. F., Adams, G. K., Andersen, I., and Man, S. F. (1978) Nasal mucociliary clearance in man. Ciba Found. Symp. 54, 219–234.

    PubMed  Google Scholar 

  17. Schlesinger, R. B. and Lippmann, M. (1972) Particle deposition in casts of the human upper tracheobronchial tree. Am. Ind. Hyg. Assoc. J. 33, 237–251.

    PubMed  CAS  Google Scholar 

  18. Svartengren, K., Philipson, K., Svartengren, M., Anderson, M., and Camner, P. (1996) Tracheobronchial deposition and clearance in small airways in asthmatic subjects. Eur. Respir. J. 9, 1123–1129.

    Article  PubMed  CAS  Google Scholar 

  19. Oldham, M. J. and Phalen, R. F. (2002) Dosimetry implications of upper tracheobronchial airway anatomy in two mouse varieties. Anat. Rec. 268, 59–65.

    Article  PubMed  Google Scholar 

  20. Spritzer, A. A., Watson, J. A., Auld, J. A. (1967) Mucociliary clearance rates. Deposition and clearance in the tracheobronchial tree of rats. Arch. Environ. Health. 15, 39–47.

    PubMed  CAS  Google Scholar 

  21. Ilowite, J. S., Smaldone, G. C., Perry, R. J., Bennett, W. D., and Foster, W. M. (1989) Relationship between tracheobronchial particle clearance rates and sites of initial deposition in man. Arch. Environ. Health 44, 267–273.

    Article  PubMed  CAS  Google Scholar 

  22. Bachofen, H. and Schurch, S. (2001) Alveolar surface forces and lung architecture. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 129, 183–193.

    Article  PubMed  CAS  Google Scholar 

  23. Oberdorster, G. (1992) Pulmonary deposition, clearance and effects of inhaled soluble and insoluble cadmium compounds. IARC Sci. Publ. 118, 189–204.

    PubMed  CAS  Google Scholar 

  24. Gehr, P., Green, F. H., Geiser, M., Im Hof, V., Lee, M. M., and Schurch, S. (1996) Airway surfactant, a primary defense barrier: mechanical and immunological aspects. J. Aerosol Med. 9, 163–181.

    PubMed  CAS  Google Scholar 

  25. Schlesinger, R. B., Vollmuth, T. A., Naumann, B. D., and Driscoll, K. E. (1986) Measurement of particle clearance from the alveolar region of the rabbit respiratory tract. Fundam. Appl. Toxicol. 7, 256–263.

    Article  PubMed  CAS  Google Scholar 

  26. Pavia, D. (1991) Bronchoalveolar clearance. Respiration 58(Suppl 1), 13–17.

    PubMed  Google Scholar 

  27. Lehnert, B. E. (1992) Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung. Environ. Health Perspect. 97, 17–46.

    Article  PubMed  CAS  Google Scholar 

  28. Gradon, L. and Podgorski, A. (1995) Displacement of alveolar macrophages in air space of human lung. Med. Biol. Eng. Comput. 33, 575–581.

    Article  PubMed  CAS  Google Scholar 

  29. Kaltreider, H. B. (1976) Expression of immune mechanisms in the lung. Am. Rev. Respir. Dis. 113, 347–379.

    PubMed  CAS  Google Scholar 

  30. Bienenstock, J., Johnston, N., and Perey, D. Y. (1973) Bronchial lymphoid tissue. I. Morphologic characteristics. Lab. Invest. 28, 686–692.

    PubMed  CAS  Google Scholar 

  31. Bienenstock, J., Johnston, N., and Perey, D. Y. (1973) Bronchial lymphoid tissue. II. Functional characterisitics. Lab. Invest. 28, 693–698.

    PubMed  CAS  Google Scholar 

  32. Bienenstock, J., McDermott, M. R., and Befus, A. D. (1982) The significance of bronchus-associated lymphoid tissue. Bull. Eur. Physiopathol. Respir. 18, 153–177.

    PubMed  CAS  Google Scholar 

  33. Murray, M. J. and Driscoll, K. E. (1992) Immunology of the respiratory system, in: Comparative Biology of the Normal Lung. Vol. 1. (Parent, R. A., ed.), CRC, Baton Rouge, LA, pp. 725–746.

    Google Scholar 

  34. Holt, P. G. (2000) Antigen presentation in the lung. Am. J. Respir. Crit. Care Med. 162, S151–S156.

    PubMed  CAS  Google Scholar 

  35. Geiser, M. (2002) Morphological aspects of particle uptake by lung phagocytes. Microsc. Res. Tech. 57, 512–522.

    Article  PubMed  Google Scholar 

  36. Holt, P. G. and Stumbles, P. A. (2000) Characterization of dendritic cell populations in the respiratory tract. J. Aerosol Med. 13, 361–367.

    PubMed  CAS  Google Scholar 

  37. Kradin, R., MacLean, J., Duckett, S., Schneeberger, E. E., Waeber, C., and Pinto, C. (1997) Pulmonary response to inhaled antigen: neuroimmune interactions promote the recruitment of dendritic cells to the lung and the cellular immune response to inhaled antigen. Am. J. Pathol. 150, 1735–1743.

    PubMed  CAS  Google Scholar 

  38. Reynolds, H. Y. (2000) Advances in understanding pulmonary host defense mechanisms: dendritic cell function and immunomodulation. Curr. Opin. Pulm. Med. 6, 209–216.

    Article  PubMed  CAS  Google Scholar 

  39. Wilkes, D. S. and Twigg, H. L. B-lymphocytes in the lung: a topic to be revisited. Sarcoidosis Vasc. Diffuse. Lung Dis. 18, 34–49.

    Google Scholar 

  40. Palliser, D., Lowrey, J. A., Lamb, J. R., and Hoyne, G. F. (1998) T-cell response to inhaled antigen. Chem. Immunol. 71, 161–177.

    Article  PubMed  CAS  Google Scholar 

  41. Lowell, G. H., Colleton, C., Frost, D., et al. (1996) Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines. Infect. Immun. 64, 4686–4693.

    PubMed  CAS  Google Scholar 

  42. Boles, J. W., Pitt, M. L., LeClaire, R. D., et al. (2003) Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity. Clin. Immunol. 108, 51–59.

    Article  PubMed  CAS  Google Scholar 

  43. Stiles, B. G., Garza, A. R., Ulrich, R. G., and Boles, J. W. (2001) Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model. Infect. Immun. 69, 2031–2036.

    Article  PubMed  CAS  Google Scholar 

  44. Vogel, P., Abplanalp, D., Kell, W., et al. (1996) Venezuelan equine encephalitis in BALB/c mice: kinetic analysis of central nervous system infection following aerosol or subcutaneous inoculation. Arch. Pathol. Lab. Med. 120, 164–172.

    PubMed  CAS  Google Scholar 

  45. Hart, M. K., Pratt, W., Panelo, F., Tammariello, R., and Dertzbaugh, M. (1997) Venezuelan equine encephalitis virus vaccine induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice. Vaccine 15, 363–369.

    Article  PubMed  CAS  Google Scholar 

  46. Hart, M. K., Caswell-Stephan, K., Bakken, R., et al. (2000) Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate. Vaccine 18, 3067–3075.

    Article  PubMed  CAS  Google Scholar 

  47. Druett, H. A., Henderson, D. W., and Peacock, S. (1956) Studies on respiratory infection. III. Experiments with Brucella suis. J. Hyg. Camb. 54, 49–57.

    PubMed  CAS  Google Scholar 

  48. Druett, H. A., Henderson, D. W., Packman, L., and Peacock, S. (1953) Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores. J. Hyg. Camb. 54, 359–371.

    Google Scholar 

  49. Druett, H. A., Henderson, D. W., Packman, L., and Peacock, S. (1956) Studies on respiratory infection. I. The influence of aerosol particle size on infection of guinea-pig with Pasturella Pestis. J. Hyg. 54, 37–48.

    Article  CAS  Google Scholar 

  50. Roy, C. J., Hale, M., Hartings, J. M., Pitt, L., and Duniho, S. (2003) Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in BALB/c mice. Inhal. Toxicol. 15, 619–638.

    Article  PubMed  CAS  Google Scholar 

  51. Fritz, D. L., Jaax, N. K., Lawrence, W. B., et al. (1995) Pathology of experimental inhalation anthrax in the rhesus monkey. Lab. Invest. 73, 691–702.

    PubMed  CAS  Google Scholar 

  52. Ivins, B. E., Fellows, P. F., Pitt, M. L. M., et al. (1996) Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Med. Bull. Special Suppl 87, 125,126.

    Google Scholar 

  53. Welkos, S. L., Keener, T. J., and Gibbs, P. H. (1986) Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 51, 795–800.

    PubMed  CAS  Google Scholar 

  54. Welkos, S. L. anf Friedlander, A. M. (1988) Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microb. Pathog. 5, 127–139.

    Article  PubMed  CAS  Google Scholar 

  55. Haines, B. W., Kleain, F., and Lincoln, R. E. (1965) Quantitiative assay for crude anthrax toxins. J. Bacteriol. 89, 74–83.

    PubMed  CAS  Google Scholar 

  56. Lincoln, R. E., Walker, J. S., Klein, F., Rosenwald, A. J., and Jones, W. I., Jr. (1967) Value of field data for extrapolation in anthrax. Fed. Proc. 26, 1558–1562.

    Google Scholar 

  57. Ivins, B. E., Fellows, P. F., and Nelson, G. O. (1994) Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs. Vaccine 12, 872–874.

    Article  PubMed  CAS  Google Scholar 

  58. Fellows, P. F., Linscott, M. K., Ivins, B. E., et al. (2001) Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine 19, 3241–3247.

    Article  PubMed  CAS  Google Scholar 

  59. Zaucha, G. M., Pitt, L. M., Estep, J., Ivins, B. E., and Friedlander, A. M. (1998) The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch. Pathol. Lab. Med. 122, 982–992.

    PubMed  CAS  Google Scholar 

  60. Pitt, M. L., Little, S. F., Ivins, B. E., et al. (2001) In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine 19, 4768–4773.

    Article  PubMed  CAS  Google Scholar 

  61. Yersin, N. B. and Carre, M. (1904) Sur la vaccination contre la peste au moyen du virus attenue, Congress International de Medecine. Section de Medecine et Chirurgie Militaires. 17 Soussection coloniale, Paris.

    Google Scholar 

  62. Davis, K. J., Fritz, D. L., Pitt, M. L., Welkos, S. L., Worsham, P. L., and Friedlander, A. M. (1996) Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch. Pathol. Lab. Med. 120, 156–163.

    PubMed  CAS  Google Scholar 

  63. Middlebrook, J. L. and Franz, D. R. (1997) Botulinum toxins, in: Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. (Zatjchuk, R., ed.), Borden Institute, Washington, D.C., pp. 645.

    Google Scholar 

  64. Bavari, S., Hunt, R. E., and Ulrich, R. G. (1995) Divergence of human and nonhuman primate lymphocyte responses to bacterial superantigens. Clin. Immunol. Immunopathol. 76, 248–254.

    Article  PubMed  CAS  Google Scholar 

  65. Boles, J. W., Pitt, M. L., LeClaire, R. D., Gibbs, P. H., Ulrich, R. G., and Bavari, S. (2003) Correlation of body temperature with protection against staphylococcal enterotoxin B exposure and use in determining vaccine dose-schedule. Vaccine 21, 2791–2796.

    Article  PubMed  CAS  Google Scholar 

  66. Stiles, B. G., Bavari, S., Krakauer, T., and Ulrich, R. G. (1993) Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect. Immun. 61, 5333–5338.

    PubMed  CAS  Google Scholar 

  67. DaSilva, L., Welcher, B. C., Ulrich, R. G., Aman, M. J., David, C. S., and Bavari, S. (2002) Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J. Infect. Dis. 185, 1754–1760.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Aerobiology and Product Evaluation, US Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD

    M. Louise M. Pitt PhD

  2. Toxinology and Aerobiology Division, US Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD

    M. Louise M. Pitt PhD & Ross D. LeClaire DVM, PhD (Chief)

  3. US Army Center for Health Promotion and Preventive Medicine, Camp Zama, Japan

    Ross D. LeClaire DVM, PhD (Chief)

Authors
  1. M. Louise M. Pitt PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ross D. LeClaire DVM, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Homeland Security, Science and Technology Directorate, National Biodefense Analysis and Countermeasures Center, Fort Detrick, MD

    Luther E. Lindler PhD  & George W. Korch PhD (Deputy Director) &  (Deputy Director)

  2. Department of Bacterial Diseases, Walter Reed Army Institute of Research, Silver Spring, MD

    Luther E. Lindler PhD

  3. Department of Cell Biology and Biochemistry, US Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD

    Frank J. Lebeda PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Pitt, M.L.M., LeClaire, R.D. (2005). Pathogenesis by Aerosol. In: Lindler, L.E., Lebeda, F.J., Korch, G.W. (eds) Biological Weapons Defense. Infectious Disease. Humana Press. https://doi.org/10.1385/1-59259-764-5:065

Download citation

  • DOI: https://doi.org/10.1385/1-59259-764-5:065

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-184-4

  • Online ISBN: 978-1-59259-764-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation